Related Experiment Video
Updated: Apr 26, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
Nutritional intervention rich in tryptophan enhances sleep duration and reduces wakefulness during breast cancer
Henriqueta Vieira Van Keulen1, Guilherme Eugênio Van Keulen2, Jéssica Pereira Silva3
1Postgraduate Program in Collective Health, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Abstract:
Background: Sleep disorders are highly prevalent among women undergoing treatment for breast cancer, often exacerbated by the side effects of chemotherapy. Nutritional strategies using foods rich in tryptophan and precursors of melatonin may help regulate sleep, but evidence in cancer populations remains limited.Objective: To evaluate the effect of a tryptophan-rich dietary intervention on sleep parameters in women undergoing chemotherapy for breast cancer.Methods: Fifty women were randomized into a Sleep Diet Group (SDG) that received a tryptophan-rich meal plan (>3000 mg/day) or a Control Group (CG) that received a diet without specific foods to facilitate sleep. Sleep was monitored daily for six weeks using actigraphy (Mi Band 4C®), assessing total sleep time (TST), light sleep, deep sleep and wake after sleep onset (WASO). Fatigue and insomnia severity were assessed before and after the intervention.Results: The SDG had significantly higher TST compared to the CG in weeks 4 and 5 (p = 0.007 and p = 0.010, respectively). WASO was significantly lower in the SDG during weeks 2 and 4 (p = 0.011 and p = 0.035). No significant differences in deep sleep were observed between groups (p = 0.214). Both groups showed subjective improvements in insomnia severity, with no differences between groups. Fatigue scores remained unchanged.Conclusion: A dietary intervention with tryptophan-rich foods improved total sleep time and reduced nighttime awakenings in women undergoing breast cancer treatment. These findings suggest that targeted nutritional strategies may support sleep regulation during chemotherapy.
More Related Videos
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
07:04A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
Published on: August 19, 2018
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Cancer Prevention
Some...
REM Sleep Behavior Disorder
RBD is significantly associated with...